248 related articles for article (PubMed ID: 17493844)
1. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
[TBL] [Abstract][Full Text] [Related]
2. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
3. Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway.
Song H; Zhang J; Chiang YJ; Siraganian RP; Hodes RJ
J Immunol; 2007 Jan; 178(2):926-35. PubMed ID: 17202354
[TBL] [Abstract][Full Text] [Related]
4. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
[TBL] [Abstract][Full Text] [Related]
5. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
6. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
7. The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation.
Katkere B; Rosa S; Drake JR
J Biol Chem; 2012 May; 287(20):16636-44. PubMed ID: 22451666
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
9. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
[TBL] [Abstract][Full Text] [Related]
10. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
Lottin-Divoux S; Jean D; Le Romancer M; Frade R
Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
12. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
Gustin SE; Thien CB; Langdon WY
J Immunol; 2006 Nov; 177(9):5980-9. PubMed ID: 17056522
[TBL] [Abstract][Full Text] [Related]
13. Syk mediates BCR- and CD40-signaling integration during B cell activation.
Ying H; Li Z; Yang L; Zhang J
Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
[TBL] [Abstract][Full Text] [Related]
14. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
Vilen BJ; Burke KM; Sleater M; Cambier JC
J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
[TBL] [Abstract][Full Text] [Related]
15. Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.
Chiang YJ; Jordan MS; Horai R; Schwartzberg PL; Koretzky GA; Hodes RJ
J Biol Chem; 2009 Feb; 284(7):4429-38. PubMed ID: 19074136
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl.
Shao Y; Yang C; Elly C; Liu YC
J Biol Chem; 2004 Oct; 279(42):43646-53. PubMed ID: 15304502
[TBL] [Abstract][Full Text] [Related]
17. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase.
Panchamoorthy G; Fukazawa T; Miyake S; Soltoff S; Reedquist K; Druker B; Shoelson S; Cantley L; Band H
J Biol Chem; 1996 Feb; 271(6):3187-94. PubMed ID: 8621719
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
20. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]